Subscribe

Canadian Rheumatology Association Annual Meeting

Whistler, BC—An observational study confirms in a real-world setting that people with rheumatoid arthritis (RA) who have low disease activity (LDA) after 6 months of biologic treatment are very likely to achieve remission within the next 6 months.
Ottawa, Ontario—A simple questionnaire can help clinicians track adverse events (AEs) and plan medication adjustments in patients receiving biologic drug therapy, according to researchers at The Hospital for Sick Children in Toronto, Ontario, who presented at the recent Canadian Rheumatology Association annual meeting. By Rosemary Frei, MSc
Page 2 of 2
Results 11 - 12 of 12
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology